XELOX

XELOX is a chemotherapy regimen for treatment of colorectal cancer. It consists of Capecitabine (Xeloda) and Oxaliplatin (Eloxatin). The regimen is considered a first-line treatment for metastatic colorectal cancer.

Treatment Regimen

The XELOX regimen is typically administered in cycles. A cycle usually lasts for three weeks. During the first day of each cycle, Oxaliplatin is given intravenously over a period of two hours. Capecitabine is taken orally twice daily for the first two weeks, followed by a week of rest.

Efficacy

Several studies have shown that XELOX is as effective as the FOLFOX regimen, another first-line treatment for metastatic colorectal cancer. The choice between XELOX and FOLFOX often depends on patient preference, side effect profile, and convenience.

Side Effects

Common side effects of the XELOX regimen include nausea, vomiting, diarrhea, fatigue, and neuropathy. Severe side effects can include neutropenia, a low white blood cell count that can increase the risk of infection.

See Also

• Chemotherapy
• Colorectal cancer
• Capecitabine
• Oxaliplatin

XELOX Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski